This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Ucb Pharma Gmbh. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Inventor Anaïs Barré
Introduction
Anaïs Barré, based in Montargis, France, is a noteworthy inventor contributing to advancements in the pharmaceutical field. With a total of three patents to his name, Barré is making significant strides in developing treatments for various central nervous system (CNS) diseases. His keen focus on innovative sulfonamide compounds highlights his commitment to tackling complex health challenges.
Latest Patents
One of Barré's latest patents involves Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides. These compounds possess GPR17 modulating properties, demonstrating their potential utility in treating or preventing a variety of CNS diseases. Moreover, they are particularly effective in addressing myelinating diseases or disorders, showcasing the practical implications of his research and innovation.
Career Highlights
Anaïs Barré is associated with UCB Pharma GmbH, a prominent player in the pharmaceutical industry. His role within this esteemed company highlights his dedication to scientific advancement and innovation. Over the course of his career, Barré has remained focused on developing new solutions to improve healthcare outcomes, placing him at the intersection of research and real-world impact.
Collaborations
Throughout his career, Barré has collaborated with other accomplished professionals in the field, including Christa E. Mueller and Cécile Pegurier. These partnerships represent the collaborative spirit that often drives innovation in the pharmaceutical sector, allowing for a cross-pollination of ideas and techniques that can lead to groundbreaking discoveries.
Conclusion
In conclusion, inventor Anaïs Barré exemplifies the commitment required to drive innovation within the pharmaceutical industry. With his recent patents focusing on critical health issues and a strong collaborative network, he continues to pave the way for advancements that could significantly benefit patients suffering from CNS diseases. His contributions serve as an inspiring reminder of the importance of innovation and invention in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile